AOD-9604 Peptide Research Guide — Mechanism, Studies & Applications

What is AOD-9604?

AOD-9604 (Advanced Obesity Drug 9604) is a modified fragment of human growth hormone (hGH), specifically comprising amino acids 177-191 of the hGH polypeptide chain. This synthetic peptide was originally developed by Professor Frank Ng at Monash University in Australia as a potential anti-obesity compound.

What makes AOD-9604 unique in research is its ability to stimulate lipolysis (fat breakdown) and inhibit lipogenesis (fat formation) without the adverse effects typically associated with full-length growth hormone — such as insulin resistance, increased IGF-1 levels, or acromegaly-like symptoms.

Molecular Profile

Mechanism of Action

AOD-9604 mimics the fat-metabolizing region of growth hormone while lacking its growth-promoting effects. The proposed mechanisms include:

1. Beta-3 Adrenergic Receptor Activation: AOD-9604 is believed to interact with beta-3 adrenergic receptors on adipocytes, stimulating cyclic AMP (cAMP) production and activating hormone-sensitive lipase (HSL) for fat breakdown
2. Lipogenesis Inhibition: Research suggests AOD-9604 reduces the activity of key lipogenic enzymes, including acetyl-CoA carboxylase and fatty acid synthase, thereby inhibiting new fat formation
3. No IGF-1 Stimulation: Unlike full-length hGH, AOD-9604 does not increase IGF-1 levels, which means it does not promote cell proliferation or insulin resistance in research models
4. Cartilage Regeneration: Emerging research suggests AOD-9604 may stimulate proteoglycan and collagen synthesis in chondrocytes, indicating potential applications in cartilage repair studies

Key Research Studies

Fat Metabolism Research

In preclinical studies using obese animal models, AOD-9604 demonstrated significant reductions in body fat without affecting lean muscle mass. Subjects treated with AOD-9604 showed enhanced lipolytic activity specifically in adipose tissue, with measurable decreases in visceral fat accumulation over the study period.

Cartilage and Joint Research

Recent studies have explored AOD-9604’s potential role in osteoarthritis research. In vitro studies on human chondrocytes showed that AOD-9604 stimulated proteoglycan synthesis and promoted cartilage matrix production. The compound received TGA (Therapeutic Goods Administration, Australia) approval as an ingredient in complementary medicine for joint health.

Safety Profile in Research

AOD-9604 has shown a favorable safety profile across multiple preclinical studies. Key findings include no effect on blood glucose levels, no changes in IGF-1 concentrations, and no impact on growth parameters — making it a safer research tool compared to full-length growth hormone analogs.

Research Applications

• Obesity and Metabolic Research: Studying fat metabolism pathways without growth hormone side effects
• Cartilage Biology: Investigating chondrocyte proliferation and cartilage repair mechanisms
• Comparative Studies: Comparing fragment-based approaches vs. full-length hormone effects
• Receptor Binding Studies: Exploring beta-3 adrenergic receptor interactions
• Combination Studies: Researching synergistic effects with other metabolic peptides

Handling and Reconstitution Protocol

1. Allow the vial to reach room temperature before opening
2. Reconstitute with bacteriostatic water or sterile water
3. Add water slowly along the vial wall — do not shake or vortex
4. Gently swirl until completely dissolved
5. Reconstituted solution should be clear and colorless
6. Store reconstituted peptide at 2-8°C and use within 28 days

Why Source AOD-9604 from Aarise Healthcare?

• 99%+ purity verified by HPLC and mass spectrometry
• Certificate of Analysis (COA) provided with every batch
• GMP-compliant manufacturing and handling
• International shipping to 24+ countries
• Dedicated research compound support team

For research inquiries or to request a COA, contact Aarise Healthcare.

Frequently Asked Questions

What is AOD-9604 used for in research?

AOD-9604 is primarily used in fat metabolism research. It allows researchers to study lipolysis and lipogenesis pathways using a growth hormone fragment that doesn’t trigger IGF-1 or insulin-related side effects seen with full-length hGH.

How is AOD-9604 different from HGH?

AOD-9604 is only the 177-191 amino acid fragment of human growth hormone. It retains the fat-metabolizing properties of hGH but lacks the growth-promoting, IGF-1 stimulating, and diabetogenic effects of the full hormone.

What purity should I look for when purchasing AOD-9604?

For reliable research results, a minimum purity of 98% (HPLC verified) is recommended. Aarise Healthcare supplies AOD-9604 at 99%+ purity with full COA documentation.

How should AOD-9604 be stored?

Lyophilized (powder) form should be stored at -20°C for long-term storage. Once reconstituted, store at 2-8°C and use within 28 days. Avoid repeated freeze-thaw cycles.